Annual Revenue (as of Jun 30)
Cellectar Biosciences (NASDAQ:CLRB) reported its Q2 earnings results on Friday, August 5, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Cellectar Biosciences missed estimated earnings by 18.45%, reporting an EPS of $-1.22 versus an estimate of $-1.03.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 2.94% drop in the share price the next day.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Analyze the earnings history of Cellectar Biosciences using advanced sorting and filters.
Cellectar Biosciences Questions & Answers
Cellectar Biosciences (CLRB) is scheduled to report earnings on November 7, 2022. The last reported earnings were for reported on August 5, 2022 for Q2.
The Actual EPS was $-16.00, which beat the estimate of $-25.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.